β-adrenoceptor blockade ameliorates the clinical course of experimental allergic encephalomyelitis and diminishes its aggravation in adrenalectomized rats

European Journal of Pharmacology

Volumn 577, Issue 1-3, 2007, Pages 170-182

  Dimitrijevic M ^a   Rauski A ^a   Radojevic K ^a   Kosec, D ^a   Stanojevic S ^a   Pilipovic I ^a   Leposavic G ^a,b  

^a Immunology Research Center Belgrade   (Yugoslavia)

^b Faculty of Pharmacy   (Serbia)

Author keywords

Adrenoceptor blockade; Adrenalectomy; CD4+CD25+ peripheral blood lymphocytes; Experimental allergic encephalomyelitis

Indexed keywords

BETA ADRENERGIC RECEPTOR; PROPRANOLOL DERIVATIVE;

ADRENALECTOMY; ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; IMMUNIZATION; IMMUNOPATHOGENESIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SPINAL CORD LESION;

ADRENALECTOMY; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BRAIN; CORTICOSTERONE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOCORTICOIDS; IMMUNOENZYME TECHNIQUES; LYMPHOCYTES; MALE; PHENOTYPE; PROPRANOLOL; RATS; SERUM ALBUMIN, BOVINE;

EID: 35548963413     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.08.021     Document Type: Article

References (67)

1. Bauer J., Huitinga I., Zhao W., Lassmann H., Hickey W.F., and Dijkstra C.D. The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis. Glia 15 (1995) 437-446
2. Bedoui S., Miyake S., Straub R.H., von Hörsten S., and Yamamura T. More sympathy for autoimmunity with neuropeptide Y?. Trends Immunol. 25 (2004) 508-512
3. Berger T., Weerth S., Kojima K., Linington C., Wekerle H., and Lassmann H. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab. Invest. 76 (1997) 355-364
4. Bergquist J., Tarkowski A., Ekman R., and Ewing A. Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 12912-12916
5. Bergquist J., Tarkowski A., Ewing A., and Ekman R. Catecholaminergic suppression of immunocompetent cells. Immunol. Today 19 (1998) 562-567
6. Bergquist J., Ohlsson B., and Tarkowski A. Nuclear factor-kappa B is involved in the catecholaminergic suppression of immunocompetent cells. Ann. N.Y. Acad. Sci. 917 (2000) 281-299
7. Bohn M.C., Bloom E., Goldstein M., and Black I.B. Glucocorticoid regulation of phenylethanolamine N-methyltransferase (PNMT) in organ culture of superior cervical ganglia. Dev. Biol. 105 (1984) 130-136
8. Chelmicka-Schorr E., Checinski M., and Arnason B.G.W. Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis. J. Neuroimmunol. 17 (1988) 347-350
9. + T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur. J. Immunol. 36 (2006) 2139-2149
10. Cosentino M., Bombelli R., Ferrari M., Marino F., Rasini E., Maestroni G.J., Conti A., Boveri M., Lecchini S., and Frigo G. HPLC-ED measurement of endogenous catecholamines in human immune cells and hematopoietic cell lines. Life Sci. 68 (2000) 283-295
11. Cosentino M., Zaffaroni M., Marino F., Bombelli R., Ferrari M., Rasini E., Lecchini S., Ghezzi A., and Frigo G.M. Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosis. J. Neuroimmunol. 133 (2002) 233-240
12. Cosentino M., Zaffaroni M., Ferrari M., Marino F., Bombelli R., Rasini E., Frigo G., Ghezzi A., Comi G., and Lecchini S. Interferon-γ and interferon-β affect endogenous catecholamines in human peripheral blood mononuclear cells: implications for multiple sclerosis. J. Neuroimmunol. 162 (2005) 112-121
13. Cotecchia S., and De Blasi A. Glucocorticoids increase β-adrenoceptors on human intact lymphocytes in vitro. Life Sci. 35 (1984) 2359-2364
14. Dallman M.F., Akana S.F., Strack A.M., Hanson E.S., and Sebastian R.J. The neural network that regulates energy balance is responsive to glucocorticoids and insulin and also regulates HPA axis responsivity at a site proximal to CRF neurons. Ann. N.Y. Acad. Sci. 771 (1995) 730-742
15. del Ray A.E., Besedovsky H.O., Sorkin E., Da Prada M., and Bondiolotti G.P. Sympathetic immunoregulation: difference between high- and low-responder animals. Am. J. Physiol. 242 (1982) R30-R33
16. Dimitrijević M., Laban O., von Hörsten S., Maković B.M., and Janković B.D. Neonatal sound stress and development of experimental allergic encephalomyelitis in Lewis and DA rats. Int. J. Neurosci. 78 (1994) 135-143
17. Durant S., Duval D., and Homo-Delarche F. Potentiation by steroids of the β-adrenergic agent-induced stimulation of cyclic AMP in isolated mouse thymocytes. Biochim. Biophys. Acta, Mol. Cell. Res. 762 (1983) 315-324
18. El Behi M., Dubucquoi S., Lefranc D., Zephir H., De Seze J., Vermersch P., and Prin L. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Lett. 96 (2005) 11-26
19. Elenkov I.J., Wilder R.L., Chrousos G.P., and Vizi E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52 (2000) 595-638
20. Engelhardt B. Role of glucocorticoids on T cell recruitment across the blood-brain barrier. Z. Rheumatol. 59 Suppl. 2 (2000) 18-21
21. Ewing C., and Bernard C.C. Insights into the aetiology and pathogenesis of multiple sclerosis. Immunol. Cell. Biol. 76 (1998) 47-54
22. Feldman R.D., Hunninghake G.W., and McArdle W.L. β-Adrenergic-receptor-mediated suppression of interleukin 2 receptors in human lymphocytes. J. Immunol. 139 (1987) 3355-3359
23. Friedman E.M., and Irwin M. Central CRH suppresses specific antibody responses: effects of β-adrenoceptor antagonism and adrenalectomy. Brain Behav. Immun. 15 (2001) 65-77
24. Gärtner D., Hoff H., Gimsa U., Burmester G.-R., and Brunner-Weinzier M.C. CD25 regulatory T cells determine secondary but not primary remission in EAE: impact on long-term disease progression. J. Neuroimmunol. 172 (2006) 73-84
25. Gruber-Olipitz M., Stevenson R., Oliptz W., Wagner E., Gesslbauer B., Kungl A., and Schauenstein K. Transcriptional pattern analysis of adrenergic immunoregulation in mice. Twelve hours norepinephrine treatment alters the expression of a set of genes involved in monocyte activation and leukocyte trafficking. J. Neuroimmunol. 155 (2004) 136-142
26. Haerter K., Vroon A., Kavelaars A., Heijnen C.J., Limmroth V., Espinosa E., Schledowski M., and Elsenbruch S. In vitro adrenergic modulation of cellular immune functions in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 146 (2004) 126-132
27. Heijnen C.J., Rouppe van der Voort C., Wulffraat N., van der Net J., Kuis W., and Kavelaars A. Functional alpha 1-adrenergic receptors on leukocytes of patients with polyarticular juvenile rheumatoid arthritis. J. Neuroimmunol. 71 (1996) 223-226
28. Heppner F.L., Greter M., Marino D., Falsig J., Raivich G., Hovelmeyer N., Waisman A., Rulicke T., Prinz M., Priller J., Becher B., and Aguzzi A. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med. 11 (2005) 146-152
29. Josefsson E., Bergquist J., Ekman R., and Tarkowski A. Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology 88 (1996) 140-146
30. Karaszewski J.W., Reader A.T., Maselli R., Brown M., and Arnason B.G. Sympathetic skin responses are decreased and lymphocyte beta-adrenoreceptors are increased in progressive multiple sclerosis. Ann. Neurol. 27 (1990) 107-117
31. Karaszewski J.W., Reader A.T., Anlar B., and Arnason B.G. Increased high affinity beta-adrenergic receptor densities and cyclic AMP responses of CD8 cells in multiple sclerosis. J. Neuroimmunol. 43 (1993) 1-7
32. Kohm A.P., and Sanders V.M. Norepinephrine: a messenger from the brain to the immune system. Immunol. Today 21 (2000) 539-541
33. Lan R.Y., Ansari A.A., Lian Z.-X., and Gershwin M.E. Regulatory T cells: development, function and role in autoimmunity. Autoimmun. Rev. 4 (2005) 351-363
34. Leonard J.P., MacKenzie F.J., Patel H.A., and Cuzner M.L. Splenic noradrenergic and adrenocortical responses during the preclinical and clinical stages of adoptively transferred experimental autoimmune encephalomyelitis (EAE). J. Neuroimmunol. 26 (1990) 183-186
35. Leonard J.P., MacKenzie F.J., Patel H.A., and Cuzner M.L. Hypothalamic noradrenergic pathways exert an influence on neuroendocrine and clinical status in experimental autoimmune encephalomyelitis. Brain Behav. Immun. 5 (1991) 328-338
36. Leposavić G., Pekić S., and Kosec D. Gonadotropin-releasing hormone agonist administration affects the thymopoiesis in adult female rats independently on gonadal hormone production. Am. J. Reprod. Immunol. 53 (2005) 30-41
37. Leposavić G., Arsenović-Ranin N., Radojević K., Kosec D., Pešić V., Vidić-Danković B., Plećaš-Solarović B., and Pilipović I. Characterization of thymocyte phenotypic alterations induced by long-lasting β-adrenoceptor blockade in vivo and its effects on thymocyte proliferation and apoptosis. Mol. Cell. Biochem. 285 (2006) 87-99
38. Levine S., Sowinski R., and Steinetz B. Effects of experimental allergic encephalomyelitis on thymus and adrenal. Relation to remission and relapse. Proc. Soc. Exp. Biol. Med. 165 (1980) 218-224
39. MacKenzie F.J., Leonard J.P., and Cuzner M.L. Changes in lymphocyte β-adrenergic receptor density and noradrenaline content of the spleen are early indicators of immune reactivity in acute experimental allergic encephalomyelitis in the Lewis rat. J. Neuroimmunol. 23 (1989) 93-100
40. Mason D., MacPhee I., and Antoni F. The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunology 70 (1990) 1-5
41. McEwen B.S., Biron C.A., Brunson K.W., Bulloch K., Chambers W.H., Dhabhar F.S., Goldfarb R.H., Kitson R.P., Miller A.H., Spenser R.L., and Weiss J.M. The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res. Rev. 23 (1997) 79-133
42. Montero E., Nussbaum G., Kaye J.F., Perez R., Lage A., Ben-Nun A., and Cohen I.R. Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies. J. Autoimmun. 23 (2004) 1-7
43. Muthyala S., Wiegmann K., Kim D.H., Arnason B.G.W., and Chelmicka-Schorr E. Experimental allergic encephalomyelitis, β-adrenergic receptors and interferon gamma-secreting cells in β-adrenergic agonist treated rats. Int. J. Immunopharmacol. 17 (1995) 895-901
44. Owens M.J., and Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 91 (1991) 425-473
45. Pal E., Yamamura T., and Tabira T. Autonomic regulation of experimental autoimmune encephalomyelitis in IL-4 knockout mice. J. Neuroimmunol. 100 (1999) 149-155
46. Pekarski O., Bjork J., Hedlung G., and Andersson G. The inhibitory effect in experimental autoimmune encephalomyelitis by the immunomodulatory drug Linomide (PNU-212616) is not mediated via release of endogenous glucocorticoids. Autoimmunity 28 (1998) 235-241
47. Pender M.P. Demyelination and neurological signs in experimental allergic encephalomyelitis. J. Neuroimmunol. 15 (1987) 11-24
48. Prat A., and Antel J. Pathogenesis of multiple sclerosis. Curr. Opin. Neurol. 18 (2005) 225-230
49. Rajda C., Bencsik K., Vecsei L., and Bergquist J. Catecholamine levels in peripheral blood lymphocytes from multiple sclerosis patients. J. Neuroimmunol. 124 (2002) 93-100
50. Rauški A., Kosec D., Vidić-Danković B., Plećaš-Solarović B., and Leposavić G. Effects of beta-adrenoceptor blockade on the phenotypic characteristics of thymocytes and peripheral blood lymphocytes. Int. J. Neurosci. 113 (2003) 1653-1673
51. Rogausch H., Del Ray A., Oertel J., and Besedovsky H. Norepinephrine stimulates lymphoid cell mobilization from the perfused rat spleen via β-adrenergic receptors. Am. J. Physiol. 276 (1999) R724-R730
52. Sanders V.M., Baker R.A., Ramer-Quinn D.S., Kasprowicz D.J., Fuchs B.A., and Street N.E. Differential expression of the β2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J. Immunol. 158 (1997) 4200-4210
53. Smith T., Schmied M., Adrian K., Hewson A.K., Lassmann H., and Cuzner M.L. Apoptosis of T cells and macrophages in the central nervous system of intact and adrenalectomized Lewis rats during experimental allergic encephalomyelitis. J. Autoimmun. 9 (1996) 167-174
54. Song F., Guan Z., Gienapp I.E., Shawler T., Benson J., and Whitacre C.C. The thymus plays a role in oral tolerance in experimental autoimmune encephalomyelitis. J. Immunol. 177 (2006) 1500-1509
55. Stefferl A., Linington C., Holsboer F., and Reul J.M.H.M. Susceptibility and resistance to experimental allergic encephalomyelitis: relationship with hypothalamic-pituitary-adrenocortical axis responsiveness in the rat. Endocrinology 140 (1999) 4932-4938
56. Sternberg E.M., Young W.S., Bernandini R., Calogero A.E., Chrousos G.P., Gold P.W., and Wilder R.L. A central nervous system defect in biosynthesis of corticotrophin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 4771-4775
57. Swanborg R.H. Experimental autoimmune encephalomyelitis in the rat: lessons in T-cell immunology and autoreactivity. Immunol. Rev. 184 (2001) 129-135
58. + T cells exposed to norepinephrine. J. Immunol. 166 (2001) 232-240
59. Tsunoda I., and Fujinami R.S. Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J. Neuropathol. Exp. Neurol. 55 (1996) 673-686
60. van der Veen R.C., Dietlin T.A., Pen L., Gray J.D., and Hofman F.M. Antigen presentation to Th1 but not Th2 cells by macrophages results in nitric oxide production and inhibition of T cell proliferation: interferon-gamma is essential but not sufficient. Cell. Immunol. 206 (2000) 125-135
61. Villas P.A., Dronsfield M.J., and Blankenhorn E.P. Experimental allergic encephalomyelitis and corticosterone studies in resistant and susceptible rat strains. Clin. Immunol. Immunopathol. 61 (1991) 29-40
62. Vroon A., Lombardi M.S., Kavelaars A., and Heijnen C.J. Changes in the G-protein-coupled receptor desensitization machinery during relapsing-progressive experimental allergic encephalomyelitis. J. Neuroimmunol. 137 (2003) 79-86
63. Wang Z., Hong J., Sun W., Xu G., Li N., Chen X., Liu A., Xu L., Sun B., and Zhang J.Z. Role of IFN-γ in induction of Foxp3 and conversion of CD4+ CD25- T cells to CD4+ Tregs. J. Clin. Invest. 116 (2006) 2434-2441
64. Webster J.I., Tonelli L., and Sternberg E.M. Neuroendocrine regulation of immunity. Annu. Rev. Immunol. 20 (2002) 125-163
65. White S.R., Black P.C., Samathanam G.K., and Paros K.C. Prazosin suppresses development of axonal damage in rats inoculated for experimental allergic encephalomyelitis. J. Neuroimmunol. 39 (1992) 211-218
66. Wilckens T., and De Rijk R. Glucocorticoids and immune function: unknown dimension and new frontiers. Immunol. Today 18 (1997) 418-424
67. Zoukos Y., Leonard J.P., Thomaides T., Thompson A.J., and Cuzner M.L. β-Adrenergic receptor density and function of peripheral blood mononuclear cells are increased in multiple sclerosis: a regulatory role for cortisol and interleukin-1. Ann. Neurol. 31 (1992) 657-662